AIDS INFORMATION NEWSLETTER Michael Howe, MSLS, Editor AIDS Information Center VA Medical Center, San Francisco (415) 221-4810 ext 3305 June 30, 1995 Opportunistic Infections (Part III) Bibliography of OI Review Articles - Section B [Editor's Note: This is the second of three parts of a bibliography that includes references for review articles for opportunistic infections.] IV. INFECTIONS - MYCOBACTERIAL A. MYCOBACTERIUM AVIUM COMPLEX (MAC) 1. Benson C. Disseminated Mycobacterium avium Complex Disease in Patients with AIDS. AIDS Research and Human Retroviruses. 1994;10(8):913-916. 2. Benson CA. Ellner JJ. Mycobacterium avium Complex Infection and AIDS: Advances in Therory and Practice. Clinical Infectious Diseases. 1993;17:7-20. 3. Chaisson RE. Benson CA. Dube MP. et al. Clarithromycin Therapy for Bacteremic Mycobacterium avium Complex Disease. Annals of Internal Medicine. 1994;121(12):905- 911. 4. Dautzenberg B. Truffot C. Legris S. Activity of Clarithromycin against Mycobacterium avium Infection in Patients with the Acquired Immune Deficiency Syndrome: A Controlled Clinical Trial. American Review of Respiratory Disease. 1991;144:564-9. 5. Inderlied CB. Kemper CA. Bermudez LE. The Mycobacterium avium Complex. Clinical Microbiology Reviews. 1993 July;6(3):266-310. 6. Maddix DS. Tallian KB. Mead PS. Rifabutin: A Review with Emphasis on its Role in the Prevention of Disseminated Mycobacterium avium Complex Infection. Annals of Pharmacotherapy. 1994;28:1250-54. 7. Nightingale SD. Cameron WD. Gordin FM. et al. Two Controlled Trials on Rifabutin Prophylaxis Against Mycobacterium avium Complex Infection in AIDS. New England Journal of Medicine. 1993 Sept;329(12):828-33. 8. Northfelt DW. Mycobacterium avium Complex Infection in AIDS: Clinical Presentation, Diagnosis, and Current Therapy. AIDS Reader. 1993;3(2):40-6. 9. Peloquin CA. Controversies in the Management of Mycobacterium avium Complex Infection in AIDS Patients. Annals of Pharmacotherapy. 1993 27:928-37. 10. Recommendations on Prophylaxis and Therapy for Disseminated Mycobacterium avium Complex Disease in Patients Infected with the Human Immunodeficiency Virus. New England Journal of Medicine. 1993 Sept;329(12):898- 904. 11. Rifabutin. The Medical Letter on Drugs and Terapeutics. 1993;35(Issue 895):36-8. 12. Rubin DS. Rahal JJ. Mycobacterium-avium Complex. Infectious Disease Clinics of North America. 1994;8(2):413-426. B. TUBERCULOSIS 1. Barnes PF. Barrows SA. Tuberculosis in the 1990s. Annals of Internal Medicine. 1993;119:400-10. 2. Centers for Disease Control and Prevention. Initial Therapy for Tuberculosis in the Era of Multidrug Resistance: Recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR. 1992 May 21;42(No. RR-7):[inclusive page numbers]. 3. Centers for Disease Control and Prevention. Management of Persons Exposed to Multidrug-Resistant Tuberculosis. MMWR. 1992 Jun 19;41(No. RR-11):61-71. 4. Cohn DL. Treatment and Prevention of Tuberculosis in HIV- Infected Persons. Infectious Disease Clinics of North America. 1994;8(2):399-412. 5. Colditz GA. Brewer TF. Berkey CS. et al. Efficacy of BCG Vaccine in the Prevention of Tuberculosis: Meta-Analysis of the Published Literature. JAMA. 1994;271(9):698-702. 6. Drugs for Tuberculosis. The Medical Letter on Drugs and Therapeutics. 1992;34(Issue 863):10-12. 7. Houston S. Fanning A. Current and Potential Treatment of Tuberculosis. Drugs. 1994;48(5):689-708. 8. Jacobs RF. Multiple-Drug-Resistant Tuberculosis. Clinical Infectious Diseases. 1994;19:1-10. 9. Mycobacterial Diseases in HIV Infection. AIDSFILE. 1992;6(4):[pages inclusive]. 10. Peloquin CA. Berning SE. Infection Caused by Mycobacterium Tuberculosis. Annals of Pharmacotherapy. 1994;28:72-83. 11. Riley LW. Drug-Resistant Tuberculosis. Clinical Infectious Diseases. 1993;17(Suppl 2):S442-6. 12. Small PM. Shafer RW. Hopewell PC. et al. Exogenous Reinfection with Multidrug-Resistant Mycobacterium Tuberculosis in Patients with Advanced HIV Infection. New England Journal of Medicine. 1993 Apr 22;328(16):1137- 44. V. Infections - Parasitic A. Review Articles - General 1. Drugs for Parasitic Infections. The Medical Letter on Drugs and Therapeutics. 1993; 35(Issue 911):111-22. 2. Parasitic Diseases in HIV Infection. AIDSFILE. 1994;8(3):[pages inclusive]. B. CRYPTOSPORIDIOSIS 1. Bissuel F. Cotte L. Rabodonirina M. et al. Paromomycin: An Effective Treatment for Cryptosporidial Diarrhea in Patients with AIDS. Clinical Infectious Diseases. 1994;18:447-449. 2. Fichtenbaum CJ. Ritchie DJ. Powderly WG. Use of Paromomycin for Treatment of Cryptosporidiosis in Patients with AIDS. Clinical Infectious Diseases. 1993 Feb;16:298-300. 3. Lecuit M. Oksenhendler E. Sarfati C. Use of Albendazole for Disseminated Microsporidian Infection in a Patient with AIDS. Clinical Infectious Diseases. 1994;19:332- 333. 4. Mannheimer SB. Soave R. Protozoal Infections in Patients with AIDS: Cryptosporidiosis, Isosporiasis, Cyclosporiasis, and Microsporidiosis. Infectious Disease Clinics of North America. 1994;8(2):483-498. 5. Petersen C. Cryptosporidiosis in Patients Infected with the Human Immunodeficiency Virus. Clinical Infectious Diseases. 1992;15:903-9. 6. Soave R. Cryptosporidium in HIV Infection. AIDS Reader. 1993 Jan/Feb;3(1):29-32. 7. Soave R. Treatment Strategies for Cryptosporidiosis. Annals of the New York Academy of Sciences. 1990;616:442- 50. 8. White AC. Chappell CL. Hayat CS. Paromomycin for Cryptosporidiosis in AIDS: A Prospective, Double-Blind Trial. Journal of Infectious Diseases. 1994;170:419-24. C. PNEUMOCYSTIS CARINII PNEUMONIA 1. Dohn MN. Weinberg WG. Torres RA. et al. Oral Atovaquone Compared with Intravenous Pentamidine for Pneumocystis carinii Pneumonia in Patients with AIDS. Annals of Internal Medicine. 1994;121:174-180. 2. Girard PM. Landman R. Gaudebout C. et al. Dapsone- Pyrimethamine Compared with Aerosolized Pentamidine as Primary Prophylaxis Against Pneumocystis carinii Pneumonia and Toxoplasmosis in HIV Infection. New England Journal of Medicine. 1993 May;328(21):1514-20. 3. Haile LG. Flaherty JF. Atovaquone: A Review. Annals of Pharmacotherapy. 1993 Dec;27:1488-94. 4. Hughes W. Leoung G. Kramer F. et al. Comparison of Atovaquone (566C80) with Trimethoprim-Sulfamethoxazole to Treat Pneumycystis carinii Pneumonia in Patients with AIDS. New England Journal of Medicine. 1993 May;328(21):1521-7. 5. Kovacs JA. Masur H. Prophylaxis for Pneumocystis carinii Pneumonia in Patients Infected with Human Immunodeficiency Virus. Clinical Infectious Diseases. 1992;14:1005-9. 6. Lee BL. Medina I. Benowitz NL. Dapsone, Trimethoprim, and Sulfamethoxazole Plasma Levels during Treatment of Pneumocystis Pneumonia in Patients with the Acquired Immunodeficiency Syndrome (AIDS): Evidence of Drug Interactions. Annals of Internal Medicine. 1989;110:606- 11. 7. Masur H. Prevention and Treatment of Pneumocystis Pneumonia. New England Journal of Medicine. 1992 Dec 24;327(26):1853-60. 8. Miller RF. Mitchell DM. AIDS and the Lung: Update 1992. 1. Pneumocystis carinii Pneumonia. Thorax. 1992 Apr;47(4):305-14. 9. Moe AA. Hardy WD. Pneumocystis carinii Infection in the HIV-Seropositive Patient. Infectious Disease Clinics of North America. 1994;8(2):331-364. 10. Recommendations for Prophylaxis Against Pneumocystis carinii Pneumonia for Adults and Adolescents Infected with Human Immunodeficiency Virus. MMWR. 1992:41(No. RR- 4):1-11. 11. Recommendations for Prophylaxis Against Pneumocystis carinii Pneumonia for Persons with Human Immunodeficiency Virus. Journal of AIDS. 1993;6:46-55. 12. Safrin S. New Developments in the Management of Pneumocystis carinii Disease. In: AIDS Clinical Review 1993/1994. New York: Marcel Dekker, Inc., 1994;95-112. 13. Sattler FR. Frame P. Davis R. et al. Trimetrexate with Leucovorin versus Trimethoprim-Sulfamethoxazole for Moderate to Severe Episodes of Pneumocystis carinii Pneumonia in Patients with AIDS: A Prospective, Controlled Multicenter Investigation of the AIDS Clinical Trials Group Protocol 029/031. Journal of Infectious Diseases. 1994;170:165-72. 14. Sistek CJ. Wordell CJ. Hauptman SP. Adjuvant Corticosteroid Therapy for Pneumocystis carinii Pneumonia in AIDS Patients. Annals of Pharmacotherapy. 1992 Sept;26:1127-33. 15. Toma E. Fournier S. Dumont M. et al. Clindamycin/Primaquine Versus Trimethoprim- Sulfamethoxazole as Primary Therapy for Pneumocystis carinii Pneumonia in AIDS: A Randomized, Double-Blind Pilot Trial. Clinical Infectious Diseases. 1993;17:178- 84. D. TOXOPLASMOSIS 1. Availability of Sulfadiazine -- United States. MMWR. 1992;41(50):950-1. 2. Dannemann B. McCutchan A. Israelski D. Treatment of Toxoplasmic Encephalitis in Patients with AIDS: A Randomized Trial Comparing Pyrimethamine plus Clindamycin to Pyrimethamine plus Sulfadiazine. Annals of Internal Medicine. 1992;116(1):33-43. 3. Gellin BG. Soave R. Coccidian Infections in AIDS: Toxoplasmosis, Cryptosporidiosis, and Isosporiasis. Medical Clinics of North America. 1992 Jan;76(1):205- 34. 4. Kovacs JA and the NIAID-Clinical Center Intramural AIDS Program. Efficacy of Atovaquone in Treatment of Toxoplasmosis in Patients with AIDS. Lancet. 1992 Sept 12;340:637-8. 5. Luft BJ. Hafner R. Korzun AH. et al. Toxoplasmic Encephalitis in Patients with the Acquired Immunodeficiency Syndrome. New England Journal of Medicine. 1993 Sept;329(14):995-1000. 6. Mariuz P. Bosler EM. Luft BJ. Toxoplasmosis in Individuals with AIDS. Infectious Disease Clinics of North America. 1994;8(2):365-381. 7. Moorthy RS. Smith RE. Rao NA. Progressive Ocular Toxoplasmosis in Patients with Acquired Immunodeficiency Syndrome. American Journal of Opthalmology. 1993 Jun;115(6):742-7. 8. Masur H. Polis MA. Tuazon CU. et al. Salvage Trial of Trimetrexate-Leucovorin for Treatment of Cerebal Toxoplasmosis in Patients with AIDS. Journal of Infectious Diseases. 1993 June;167:1422-6. 9. Pauwels A. Meyohas MC. Eliaszewicz M. et al. Toxoplasma Colitis in the Acquired Immunodeficiency Syndrome. American Journal of Gastroenterology. 1992;87(4):518-9. 10. Pomeroy C. Filice GA. Pulmonary Toxoplasmosis: A Review. Clinical Infectious Diseases. 1992 Apr;14:863-70. 11. Porter ST. Sande MA. Toxoplasmosis of the Central Nervous System in the Acquired Immunodeficiency Syndrome. New England Journal of Medicine. 1992;327(23):1643-8. 12. Schnapp LM. Geaghan SM. Campagna A. et al. Toxoplasma gondii Pneumonitis in Patients Infected with the Human Immunodeficiency Virus. Archives of Internal Medicine;1992 May;152:1073-7. 13. St. Georgiev V. Management of Toxoplasmosis. Drugs. 1994;48(2):179-188.